Company intelligence / Profile preview

Kostner

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Kostner is a healthcare technology company that provides an AI-driven clinical trial intelligence platform designed to optimize drug development processes. The company's software-as-a-service (SaaS) solutions assist pharmaceutical sponsors and contract research organizations (CROs) in trial design, site selection, and patient recruitment. By leveraging advanced data analytics and machine learning, Kostner aims to reduce the time and cost associated with bringing new therapies to market. Their platform integrates diverse clinical data sources to provide actionable insights for clinical operations teams.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Kostner.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kostner.

Explore the full profile